Jameson Legal

 

Resource

 

 

 

 

 

 

 

 

 

 

 

Cardinal Health sells its Cardinal Health China business to Shanghai Pharmaceuticals for $1.2 billion

03 Feb 2018

Jones Day advised Cardinal Health in the $1.2 billion sale of its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd.

For additional information about this matter, please contact: Angel Huang, Liming Yuan, Ismail H. Alsheik

Client(s): Cardinal Health, Inc.
Practice(s): M&A, Tax, Antitrust & Competition Law
Office(s): Shanghai, Chicago, Beijing, Silicon Valley, Detro

Matter Type
Asset Sale: Seller's Counsel
Industry
Healthcare, Life Sciences & Chemicals
News Category
Real Estate & Construction
M&A